Purity | Size | Price | VIP Price | USA Stock *0-1 Day | Global Stock *5-7 Days | Quantity | |||||
{[ item.p_purity ]} | {[ item.pr_size ]} |
{[ getRatePrice(item.pr_usd, 1,1) ]} {[ getRatePrice(item.pr_usd,item.pr_rate,item.mem_rate) ]} |
{[ getRatePrice(item.pr_usd, 1,1) ]} | Inquiry {[ getRatePrice(item.pr_usd,item.pr_rate,item.mem_rate) ]} {[ getRatePrice(item.pr_usd,1,item.mem_rate) ]} | {[ item.pr_usastock ]} | Inquiry - | {[ item.pr_chinastock ]} | Inquiry - |
* Storage: {[proInfo.prStorage]}
CAS No. : | 90004-94-7 | MDL No. : | MFCD11977406 |
Formula : | C8H6BrNO3 | Boiling Point : | - |
Linear Structure Formula : | - | InChI Key : | NZUHVXSDFZFAFX-UHFFFAOYSA-N |
M.W : | 244.04 | Pubchem ID : | 14503613 |
Synonyms : |
|
Num. heavy atoms : | 13 |
Num. arom. heavy atoms : | 6 |
Fraction Csp3 : | 0.12 |
Num. rotatable bonds : | 2 |
Num. H-bond acceptors : | 3.0 |
Num. H-bond donors : | 0.0 |
Molar Refractivity : | 53.16 |
TPSA : | 62.89 Ų |
GI absorption : | High |
BBB permeant : | Yes |
P-gp substrate : | No |
CYP1A2 inhibitor : | Yes |
CYP2C19 inhibitor : | Yes |
CYP2C9 inhibitor : | No |
CYP2D6 inhibitor : | No |
CYP3A4 inhibitor : | No |
Log Kp (skin permeation) : | -6.39 cm/s |
Log Po/w (iLOGP) : | 1.38 |
Log Po/w (XLOGP3) : | 1.97 |
Log Po/w (WLOGP) : | 2.56 |
Log Po/w (MLOGP) : | 1.33 |
Log Po/w (SILICOS-IT) : | 0.69 |
Consensus Log Po/w : | 1.59 |
Lipinski : | 0.0 |
Ghose : | None |
Veber : | 0.0 |
Egan : | 0.0 |
Muegge : | 0.0 |
Bioavailability Score : | 0.55 |
Log S (ESOL) : | -2.8 |
Solubility : | 0.383 mg/ml ; 0.00157 mol/l |
Class : | Soluble |
Log S (Ali) : | -2.92 |
Solubility : | 0.296 mg/ml ; 0.00121 mol/l |
Class : | Soluble |
Log S (SILICOS-IT) : | -2.97 |
Solubility : | 0.26 mg/ml ; 0.00107 mol/l |
Class : | Soluble |
PAINS : | 0.0 alert |
Brenk : | 2.0 alert |
Leadlikeness : | 1.0 |
Synthetic accessibility : | 1.98 |
Signal Word: | Warning | Class: | N/A |
Precautionary Statements: | P261-P305+P351+P338 | UN#: | N/A |
Hazard Statements: | H302-H315-H319-H335 | Packing Group: | N/A |
GHS Pictogram: |
* All experimental methods are cited from the reference, please refer to the original source for details. We do not guarantee the accuracy of the content in the reference.
Yield | Reaction Conditions | Operation in experiment |
---|---|---|
85% | at 90℃; for 1 h; | Iron powder (5.69 g, 102.0 mmol) was added to a solution of l-(4-bromo-2- nitropheny ethanone (62, 4.16 g, 17.0 mmol) in 30 mL of acetic acid and the resulting suspension was heated to 90 °C for 1 hour. After cooling to room temperature the reaction mixture was diluted with brine and EtOAc and adjusted to pH 10 by the addition of 3N aqueous NaOH. The mixture was filtered and the filtrate was extracted 3x with EtOAc. The combined organic phases were dried with Na2S04, filtered and the filtrate concentrated under vacuum to give of 1 -(2-amino-4- bromophenyl)ethanone (63, 3.1 g, 14.4 mmol, 85percent). MS: 214.0 m/z (M+H)+. |
[ 127413-59-6 ]
1-(3-Bromo-5-nitrophenyl)ethanone
Similarity: 0.90
[ 18640-58-9 ]
1-(4-Bromo-3-nitrophenyl)ethanone
Similarity: 0.86
[ 69976-70-1 ]
1-(5-Methyl-2-nitrophenyl)ethanone
Similarity: 0.85
[ 127413-59-6 ]
1-(3-Bromo-5-nitrophenyl)ethanone
Similarity: 0.90
[ 18640-58-9 ]
1-(4-Bromo-3-nitrophenyl)ethanone
Similarity: 0.86
[ 127413-59-6 ]
1-(3-Bromo-5-nitrophenyl)ethanone
Similarity: 0.90
[ 18640-58-9 ]
1-(4-Bromo-3-nitrophenyl)ethanone
Similarity: 0.86
[ 69976-70-1 ]
1-(5-Methyl-2-nitrophenyl)ethanone
Similarity: 0.85
[ 155694-84-1 ]
1-(4-Methyl-2-nitrophenyl)ethanone
Similarity: 0.84
[ 29124-56-9 ]
1-(2-Amino-5-bromophenyl)ethanone
Similarity: 0.80
[ 127413-59-6 ]
1-(3-Bromo-5-nitrophenyl)ethanone
Similarity: 0.90
[ 18640-58-9 ]
1-(4-Bromo-3-nitrophenyl)ethanone
Similarity: 0.86
[ 69976-70-1 ]
1-(5-Methyl-2-nitrophenyl)ethanone
Similarity: 0.85